成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 65271-80-9 Chemical Structure| 65271-80-9

Structure of Mitoxantrone
CAS No.: 65271-80-9

Chemical Structure| 65271-80-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 65271-80-9

,{[proInfo.pro_purity]}

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

Synonyms: Mitozantrone; NSC 301739

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Shinyoung Choi ;

Abstract: The groundbreaking Palladium/norbornene cooperative catalysis, also known as the Catellani reaction, was pioneered by Prof. Marta Catellani in 1997. This transformative reaction integrates the merits of traditional cross-coupling reactions and ortho-functionalization into a single process, offering a remarkably step-economical way to access complex polysubstituted aromatic compounds. Its versatility has proven invaluable to both organic chemists and material scientists alike. Within this dissertation, I explore my profound fascination with leveraging the Catellani reaction for methodology development in azaborine functionalization, and the synthesis of various materials such as dendrons and graphene nanoribbons. While engaging in the synthesis of graphene nanoribbons aimed for potential biomedical applications, my interest in graphene-based nanomaterials for such purposes grew stronger. Consequently, the final chapter of this dissertation offers a comprehensive review of graphene-based nanomaterials within the context of biomedical applications. Details

Purchased from AmBeed: ; ;

Yazdani, Kamyar ; Seshadri, Srinath ; Tillo, Desiree ; Yang, Mo ; Sibley, Christopher D. ; Vinson, Charles , et al.

Abstract: DNA i-motifs (iMs) are non-canonical C-rich secondary structures implicated in numerous cellular processes. Though iMs exist throughout the genome, our understanding of iM recognition by proteins or small mols. is limited to a few examples. We designed a DNA microarray containing 10976 genomic iM sequences to examine the binding profiles of four iM-binding proteins, mitoxantrone and the iMab antibody. iMab microarray screens demonstrated that pH 6.5, 5% BSA buffer was optimal, and fluorescence was correlated with iM C-tract length. hnRNP K broadly recognizes diverse iM sequences, favoring 3-5 cytosine repeats flanked by thymine-rich loops of 1-3 nucleotides. Array binding mirrored public ChIP-Seq datasets, in which 35% of well-bound array iMs are enriched in hnRNP K peaks. In contrast, other reported iM-binding proteins had weaker binding or preferred G-quadruplex (G4) sequences instead. Mitoxantrone broadly binds both shorter iMs and G4s, consistent with an intercalation mechanism. These results suggest that hnRNP K may play a role in iM-mediated regulation of gene expression in vivo, whereas hnRNP A1 and ASF/SF2 are possibly more selective in their binding preferences. This powerful approach represents the most comprehensive investigation of how biomols. selectively recognize genomic iMs to date.

Purchased from AmBeed:

Alternative Products

Product Details of Mitoxantrone

CAS No. :65271-80-9
Formula : C22H28N4O6
M.W : 444.48
SMILES Code : O=C1C2=C(C(NCCNCCO)=CC=C2NCCNCCO)C(C3=C(O)C=CC(O)=C13)=O
Synonyms :
Mitozantrone; NSC 301739
InChI Key :KKZJGLLVHKMTCM-UHFFFAOYSA-N
Pubchem ID :4212

Safety of Mitoxantrone

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H350-H410
Precautionary Statements:P201-P273-P308+P313
Class:9
UN#:3077
Packing Group:

Related Pathways of Mitoxantrone

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01142466 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 4 Completed - -
NCT01142466 - Completed - -
NCT01055483 Acute Myeloid Leukemia Phase 1 Completed - France ... More >> Novartis Investigative Site Paris Cedex 4, France, 75181 Novartis Investigative Site Paris, France, 75475 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT00002498 Breast Cancer Phase 2 Unknown - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 ZA St. Radboud University Hospital Nijmegen, Netherlands, 6500 HB Less <<
NCT00219908 Relapsing-Remitting Multiple S... More >>clerosis Less << PHASE2 TERMINATED 2025-06-06 H?pital Cote de Nacre, Caen, 1... More >>4033, France|H?pital Gabriel Montpied, Clermont-Ferrand, 63003, France|CHU Henri Mondor, Creteil, 94000, France|H?pital Général, Dijon, 21033, France|CHU Limoges, Limoges, 87042, France|Institut Catholique de Lille, Lomme, 59462, France|Pierre Weitheimer Hospital, Lyon, 69394, France|Chu Timone, Marseille, 13385, France|Centre Guy de Chauliac, Montpellier, 34295, France|CHU H?pital Central, Nancy, 54035, France|CHU, Nice, 06000, France|CHU Pitié-Salpétrière, Paris, 75013, France|H?pital Saint-Anne, Paris, 75014, France|Centre Fondation Rotschild, Paris, 75019, France|Tenon Hospital, Paris, 759170, France|CHU Strasbourg, Strasbourg, 67000, France|CHU Purpan, Toulouse, 31059, France|Psichiatriche dell'Università di Bari, Policlinico, Bari, 70122, Italy|Dipartimento di Scienze Neurologiche e Psichiatriche, Firenze, 50134, Italy|Hospedal Civile, Gallarate, 21013, Italy|Neuroriabilitazione dell'Università, Genova, 16132, Italy|Fondazionz SAN Raffaele del monte tabor, Milano, 20132, Italy|Clinica Neurologica Università di Torino, Torino, 10126, Italy Less <<
NCT00510887 Lymphoma, Follicular Phase 2 Terminated(Low accrual.) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00656084 Relapsed or Refractory Mantle ... More >>Cell Lymphoma (MCL) Less << Phase 2 Completed - -
NCT00510887 - Terminated(Low accrual.) - -
NCT00656084 - Completed - -
NCT00577993 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00185445 Non Hodgkin Lymphoma Phase 2 Completed - Italy ... More >> Bologna, BO, Italy, 40138 Cesena, FC, Italy, 47023 Forlì, FC, Italy, 47100 Genova, GE, Italy, 16132 Roma, RM, Italy, 00144 Roma, RM, Italy, 00168 Rimini, RN, Italy, 47900 Cagliari, Italy, 09121 Firenze, Italy, 50139 Napoli, Italy, 80131 Ravenna, Italy, 48100 Roma, Italy, 00161 Siena, Italy, 53100 Udine, Italy, 33100 Less <<
NCT02687386 Solid Tumours ... More >> CNS Tumours Less << Phase 1 Recruiting April 2021 Australia, New South Wales ... More >> Sydney Children's Hospital Recruiting Randwick, New South Wales, Australia, 2031 Contact: David Ziegler, MBBS ?? +61293821730 ?? ?? Contact: Dominique Hess, PhD ?? +61293823122 ?? Dominique.Hess@health.nsw.gov.au ?? Principal Investigator: David Ziegler, MBBS ?? ?? ?? Sub-Investigator: Toby Trahair, MBBS ?? ?? ?? The Children's Hospital at Westmead Recruiting Westmead, New South Wales, Australia Principal Investigator: Geoff McCowage Less <<
NCT00015951 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342-1601 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT02728050 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern ?? 206-314-5944 ?? halpern2@uw.edu ?? Principal Investigator: Anna Halpern Less <<
NCT00169208 Follicular Lymphoma Phase 2 Completed - France ... More >> Service de médecine D - Maladies du Sang CHU Angers Angers, France, 49033 Service d'Hématologie H?pital Jean Minjoz Besan?on, France, 25030 H?pital Henri Mondor Créteil, France, 94010 H?pital A. Michallon BP 217X Grenoble, France, 38043 Service Oncologie - Centre Victor Hugo Le Mans, France, 72015 Service d'hématologie clinique - Centre Hospitalier du Dr Schaffner Lens, France, 62307 H?pital Claude Huriez - Sce des Maladies du Sang - Place Verdun Lille, France, 59037 Centre Hospitalier Lyon-sud Lyon, France, 69310 Centre régional de lutte contre le cancer Léon Bérard Lyon, France, 69373 Service d'hématologie Institut Paoli Calmette Marseille, France, 13273 Service d'hématologie - H?pital Necker Paris, France, 75015 Service d'Hématologie H?pital St Louis Paris, France, 75475 Service d'hématologie clinique - H?pital de Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Service Oncologie CHU Bretonneau Tours, France, 37044 Service d'hématologie Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00770848 Cancer Castra... More >>te-Resistant Prostate Cancer Mestastatic Prostate Cancer Prostate Cancer Less << Phase 1 Phase 2 Completed - -
NCT01126814 Leukemia Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00003003 Leukemia Phase 1 Completed - United States, New Hampshire ... More >> Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01027923 Leukemia, Myeloid, Acute Phase 1 Terminated(Withdrawal of suppo... More >>rt from sponsor) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00774046 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01204710 Prostate Cancer Phase 2 Completed - -
NCT00774046 - Completed - -
NCT01204710 - Completed - -
NCT00017563 Prostate Cancer Phase 2 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Portland VA Medical Center Portland, Oregon, United States, 97239 Less <<
NCT00017563 - Completed - -
NCT00024492 Tumors Phase 1 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Ohio The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00182741 Prostate Cancer Phase 2 Completed - United States, Oregon ... More >> Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 Less <<
NCT00004071 Prostate Cancer Phase 2 Phase 3 Completed - United States, Florida ... More >> Comprehensive Cancer Care Specialists of Boca Raton Boca Raton, Florida, United States, 33428 Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, New York St. Vincents Comprehensive Cancer Center New York, New York, United States, 10011 Less <<
NCT00385827 - Terminated(Prematurely stopped... More >> after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.) Less << - -
NCT03735446 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 1 Not yet recruiting June 1, 2021 United States, Massachusetts ... More >> Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Eric s Winer, MD ?? 617-632-3000 ?? EricS_Winer@DFCI.HARVARD.EDU ?? Principal Investigator: Eric S. Winer, MD Less <<
NCT00327340 Prostate Cancer Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada Cross Cancer Institute Edmonton, Alberta, Canada Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada Canada, Nova Scotia QEII Health Sciences Halifax, Nova Scotia, Canada Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada London Regional Cancer Program London, Ontario, Canada Toronto Sunnybrook Toronto, Ontario, Canada Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada University of Montreal Montreal, Quebec, Canada Less <<
NCT00327340 - Completed - -
NCT00119730 Mantle Cell Lymphoma Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01133158 Non-Hodgkin's Lymphoma Phase 2 Completed - Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago, A Coru?a, Spain, 15706 Hospital Txagorritxu Vitoria, Alava, Spain, 01009 Hospital San Juan de Alicante San Juan de Alicante, Alicante, Spain, 03550 Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital de Galdakao Galdakao, Bilbao, Spain, 48960 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Fundación de Alcorcón Alcorcón, Madrid, Spain, 289222 Hospital de Getafe Getafe, Madrid, Spain, 28901 Hospital Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 28222 Hospital Son Llàtzer Palma de Mallorca, Mallorca, Spain, 07010 Hospital Son Espases Palma de Mallorca, Mallorca, Spain, 07014 Hospital Universitario Virgen de Arrixaca El Palmar, Murcia, Spain, 30120 Clínica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital Universitario de Canarias La Laguna, Tenerife, Spain, 38320 Complejo Hospitalario Universitario A Coru?a A Coru?a, Spain, 15006 Hospital del Mar Barcelona, Spain, 08003 Hospital Vall d′Hebron Barcelona, Spain, 08035 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital de Basurto Bilbao, Spain, 48013 Hospital San Pedro Alcántara Cáceres, Spain, 10002 Hospital Puerta del Mar Cádiz, Spain, 11009 Hospital de Jaén Jaén, Spain, 23007 Hospital Gregorio Mara?ón Madrid, Spain, 28009 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital La Paz Madrid, Spain, 28046 Hospital Morales Meseguer Murcia, Spain, 30008 Complejo Hospitalario Carlos Haya Málaga, Spain, 29010 Hospital de Salamanca Salamanca, Spain, 37007 Hospital General de Segovia Segovia, Spain, 42002 Hospital Virgen del Rocío Sevilla, Spain, 41013 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Hospital General de Valencia Valencia, Spain, 46014 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital Universitario Dr. Peset Valencia, Spain, 46017 Hospital Río Hortega Valladolid, Spain, 47012 Hospital Virgen de la Concha Zamora, Spain, 49022 Hospital Clínico de Zaragoza Zaragoza, Spain, 50009 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00385827 Cancer, Prostate Phase 2 Terminated(Prematurely stopped... More >> after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.) Less << - -
NCT00331344 Adenocarcinoma of the Prostate... More >> Recurrent Prostate Cancer Stage IV Prostate Cancer Less << Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143-0875 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00058084 Adenocarcinoma of the Prostate... More >> Recurrent Prostate Cancer Stage IV Prostate Cancer Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143-0875 Less <<
NCT01133158 - Completed - -
NCT00331344 - Completed - -
NCT01065727 Multiple Sclerosis Not Applicable Recruiting February 2019 France ... More >> CHU Cavale Blanche Recruiting Brest, France, 29609 Contact: Rouhart Francois, MD ?? ?? francois.rouhart@chu-brest.fr ?? CHU Rennes Recruiting Rennes, France, 35033 Contact: Emmauelle Le Page, MD ?? ?? emmanuelle.lepage@chu-rennes.fr Less <<
NCT00002544 Breast Cancer Phase 3 Completed - Germany ... More >> Diakonissen-Krankenhaus Stuttgart Stuttgart, Germany, D-70176 Less <<
NCT00003183 Prostate Cancer Phase 1 Phase 2 Unknown - United States, Kansas ... More >> Bethany Medical Center Kansas City, Kansas, United States, 66102 Heartland Cancer Research and Treatment Center Kansas City, Kansas, United States, 66106 Less <<
NCT01729845 Previously Treated Myelodyspla... More >>stic Syndrome Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 EvergreenHealth Medical Center Kirkland, Washington, United States, 98033 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01127009 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00254410 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00254410 - Completed - -
NCT03531918 Acute Myeloid Leukemia ... More >> High-Grade Myeloid Neoplasm Less << Phase 1 Phase 2 Recruiting July 1, 2025 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Roland Walters ?? 206-667-3599 ?? rwalter@fredhutch.org ?? Principal Investigator: Roland Walters Less <<
NCT00274963 Chronic Lymphocytic Leukemia Phase 2 Completed - Germany ... More >> Humaine - Clinic Bad Saarow, Germany, 15526 Schwerpunktpraxis fuer Haematologie und Internistische Onkologie Berlin, Germany, D-10117 Internistische Gemeinschaftspraxis - Halle Halle, Germany, 06110 St. Marien Hospital Hamm, Germany, 59065 Praxis fuer Haematologie und Onkologie Koblenz, Germany, D-56068 Praxis Fuer Haematologie Internistische Onkologie Koeln, Germany, D-50677 Haematologische / Onkologische Schwerpunktpraxis Krefeld, Germany, 47798 Internistische Onkologische Praxis - Kronach Kronach, Germany, 96317 Internistische Praxis - Neuss Neuss, Germany, 41460 Internistische Gemeinschaftspraxis - Oldenburg Oldenburg, Germany, 26121 Haematologische Praxis Weiden, Germany, D-92637 Deutsche Klinik fuer Diagnostik Wiesbaden, Germany, D-65191 Less <<
NCT00795002 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00004124 - Active, not recruiting - -
NCT00183989 Mantle Cell Lymphoma Phase 2 Terminated(Insufficient accrua... More >>l) Less << - United States, California ... More >> Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00795002 - Completed - -
NCT01523860 Follicular Lymphoma Phase 2 Completed - Italy ... More >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) Meldola, Forlì-Cesena, Italy, 47014 Ematologia e Trapianto Ospedale Card.Panico Tricase, Lecce, Italy Ematologia, A.O. San Gerardo Monza, Milano, Italy, 20052 Oncologia Medica ed Ematologia, Istituto Clinica Humanitas Rozzano, Milano, Italy, 20089 Divisione di Oncologia Medica A, Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 UO Oncologia ed Onco-Ematologia, Ospedale di Rimini Rimini, Rn, Italy Divisione di Ematologia Ospedale SS. Antonio e Biagio Alessandria, Italy, 15100 SOS Ematologia Ospedale C. Massaia Asti, Italy, 14100 Ematologia con Trapianto, Università di Bari Bari, Italy, 70124 Medicina Interna, Ospedale degli Infermi Biella, Italy, 13800 Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola Bologna, Italy, 40138 Divisione di Ematologia e TMO, Ospedale di Bolzano Bolzano, Italy, 39100 S.C. di Ematologia, Spedali Civili Brescia, Italy, 25123 Divisione di Ematologia, Ospedale Businco Cagliari, Italy, 09121 Divisione di Ematologia, Ospedale di Catania Catania, Italy Azienda Ospedaliera Santa Croce e Carle Cuneo, Italy, 12100 Clinica Ematologica Policlinico Carreggi Firenze, Italy, 50134 Divisione di Ematologia, Policlinico Careggi Firenze, Italy Ematologia I, A.O.U. San Martino Genova, Italy, 16132 S.C. Medicina Trasfusionale ed Ematologia , P.O. Ivrea Ivrea, Italy, 10015 S.C. Ematologia, Azienda Ospedaliera Papardo Messina, Italy, 98158 Divisione di Ematologia, Ospedale Niguarda Milano, Italy, 20162 Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori Milano, Italy Policlinico La Marcora Milano, Italy UO Ematologia, II Facoltà di Medicina e Chirurgia Università Federico II Napoli, Italy, 80131 SCDU Ematologia, AOU Maggiore della Carità Novara, Italy, 28100 UO Ematologia, Università - Policlinico San Matteo Pavia, Italy, 27100 Ematologia Ospedale Santa Maria delle Croci Ravenna, Italy, 48100 Div. Ematologia A.O. "Bianchi Melacrino Morelli" Reggio Calabria, Italy, 89100 Università Cattolica del Sacro Cuore Roma, Italy, 00168 Dipartimento di biotecnologie cellulari ed ematologia Ospedale Umberto I, Università La Sapienza Roma, Italy Ospedale Santa Maria di Terni Terni, Italy, 05100 Osp. San Giovanni Battista - Biologia Molecolare Torino, Italy, 10126 Osp. San Giovanni Battista - Ematologia 2 Torino, Italy, 10126 Ospedale S. Chiara Trento, Italy Ematologia Ospedale Santa Maria Di Ca' Foncello Treviso, Italy, 31100 Clinica di Ematologia, A.O.U. di Udine Udine, Italy, 33100 Less <<
NCT00004124 Prostate Cancer Phase 3 Active, not recruiting June 1, 2022 -
NCT00470197 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Malignant Neoplasm Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00512252 Leukemia, Myeloid, Acute Phase 1 Phase 2 Completed - United States, Missouri ... More >> Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT01729845 - Completed - -
NCT00002259 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 2 Completed - United States, New York ... More >> Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10019 Less <<
NCT00002003 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 2 Completed - United States, New Jersey ... More >> UMDNJ - New Jersy Med School Newark, New Jersey, United States, 071032714 United States, New York New York Univ Med Ctr New York, New York, United States, 10016 Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10019 Less <<
NCT00016016 Recurrent Adult Acute Lymphobl... More >>astic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT02597153 Relapsed Cutaneous T Cell Lymp... More >>hom Less << Phase 2 Terminated(Just one subject en... More >>rolled in this trial during one and a half years.) Less << October 2020 China ... More >> Beijing Cancer Hospital Beijing, China Less <<
NCT02921061 Mixed Phenotype Acute Leukemia... More >> Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent High Risk Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory High Risk Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Sarah A. Buckley ?? 206-416-5066 ?? sbuckley@fredhutch.org ?? Principal Investigator: Sarah A. Buckley Less <<
NCT00683475 Prostate Cancer Phase 2 Completed - -
NCT00512252 - Completed - -
NCT02573363 Acute Myeloid Leukemia Phase 1 Active, not recruiting January 2020 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Less <<
NCT00683475 - Completed - -
NCT00410423 Relapsed Acute Leukemia ... More >> Refractory Acute Leukemia Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00410423 - Completed - -
NCT02070458 Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT01349972 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States, 85259 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00452387 Metastatic Prostate Cancer Phase 2 Terminated(Early stopping rule... More >>) Less << - United States, California ... More >> Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Georgia Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies, PC Billings, Montana, United States, 59101 United States, Ohio Mid-Ohio Oncology/Hematology, Inc. Columbus, Ohio, United States, 43213 United States, Pennsylvania Lancaster Cancer Center Lancaster, Pennsylvania, United States, 17605 Pennsylvania Oncology Hematmology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 Less <<
NCT01349972 - Completed - -
NCT00609739 Leukemia Phase 1 Phase 2 Terminated(Low accrual) - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00452387 - Terminated(Early stopping rule... More >>) Less << - -
NCT00609739 - Terminated(Low accrual) - -
NCT02937285 Multiple Sclerosis Phase 3 Active, not recruiting November 2020 France ... More >> CHU Rennes Rennes, France Less <<
NCT00417079 - Completed - -
NCT00208975 Lymphoma Phase 2 Terminated(slow accrual) - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT03118466 AML Phase 2 Recruiting September 30, 2024 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02062 Contact: Richard Stone, MD ?? 617-632-2214 ?? Richard_Stone@dfci.harvard.edu ?? Principal Investigator: Richard Stone, MD ?? ?? ?? Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Lourdes Mendez, MD ?? 617-667-9920 ?? ?? Principal Investigator: Lourdes Mendez, MD ?? ?? ?? Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Andrew Brunner, MD ?? 617-724-1124 ?? Andrew_Brunner@DFCI.HARVARD.EDU ?? Principal Investigator: Andrew Brunner, MD Less <<
NCT01222143 Acute Myeloid Leukemia Phase 1 Phase 2 Terminated - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00407966 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT00417079 Neoplasms Pro... More >>static Neoplasms Less << Phase 3 Completed - -
NCT00407966 - Completed - -
NCT00546377 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00208975 - Terminated(slow accrual) - -
NCT00546377 - Completed - -
NCT01578343 Mantle Cell Lymphoma Phase 2 Terminated(we collected data o... More >>f a total of 19 patients for an interim analysis. but there are less than 7 responses out of the initial 19 patients.) Less << - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00146159 Secondary Progressive Multiple... More >> Sclerosis Less << PHASE3 TERMINATED - Berg, D-82335, Germany|Berlin,... More >> D-13347, Germany|Düsseldorf, D-40225, Germany|Düsseldorf, D-40479, Germany|Gie?en, D-35385, Germany|Marburg, D-35039, Germany|Wiesbaden, D-65191, Germany Less <<
NCT01522443 Prostate Cancer ... More >> Castration Resistant Prostate Cancer Pain Prostatic Neoplasms Less << Phase 3 Terminated(Stopped after the o... More >>utcome of cabozantinib Phase 3 CRPC study XL184-307.) Less << - -
NCT00003858 Prostate Cancer Phase 2 Withdrawn(The study was not ac... More >>tivated.) Less << - -
NCT01522443 - Terminated(Stopped after the o... More >>utcome of cabozantinib Phase 3 CRPC study XL184-307.) Less << - -
NCT00304291 Neuromyelitis Optica|Myelitis,... More >> Transverse|Demyelinating Autoimmune Diseases, CNS|Autoimmune Diseases of the Nervous System Less << PHASE4 COMPLETED 2025-05-04 Baird Multiple Sclerosis Cente... More >>r, Buffalo, New York, 14203, United States Less <<
NCT01342887 - Terminated - -
NCT00203073 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 2 Completed - -
NCT01768897 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02631252 Leukemia, Acute Myelogenous Phase 1 Terminated(Inability to accrue... More >>) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute - Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02044796 Acute Biphenotypic Leukemia ... More >> de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 1 Phase 2 Active, not recruiting August 1, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01342887 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Terminated - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00901927 Follicular Lymphoma Phase 2 Terminated(Study was closed ea... More >>rly due to toxicity) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00661492 Androgen-independent Prostate ... More >>Cancer Less << Phase 2 Completed - -
NCT00447473 Prostatic Neoplasms Phase 2 Terminated(PI decision) - United States, Texas ... More >> Baylor College of Medicine - Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT02484391 Granulocytic Sarcoma ... More >> Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting February 2022 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Scarlett Hutchens ?? 336-713-6915 ?? snhutche@wakehealth.edu ?? Principal Investigator: Timothy S. Pardee Less <<
NCT03504410 Relapsed/Refractory Acute Myel... More >>oid Leukemia Less << Phase 3 Recruiting March 2023 United States, North Carolina ... More >> Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Principal Investigator: Bayard L Powell, MD ?? ?? ?? United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Principal Investigator: Aziz Nazha, MD Less <<
NCT01214317 Multiple Sclerosis Not Applicable Unknown February 2012 Iran, Islamic Republic of ... More >> Alahra hospital Isfahan, Iran, Islamic Republic of Less <<
NCT02856685 Non-Hodgkin's Lymphoma Phase 1 Phase 2 Unknown May 2018 United States, Ohio ... More >> Gabrail Cancer Center Research Recruiting Canton, Ohio, United States Contact: Nashat Y Gabrail, MD Less <<
NCT01249430 Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00661492 - Completed - -
NCT00059631 Prostate Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00268242 - Terminated(If ... More >>tial 18 patients had a CR, the study would be stopped. Only 5 patients (21%) of 24 enrolled patients had a CR so the study was terminated.) Less << - -
NCT01260714 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(Inadequate accrual ... More >>rate) Less << - Canada, Ontario ... More >> Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02597387 Relapsed DLBCL and PT/NKCLs Phase 2 Recruiting October 2018 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China Contact: Mi Jiang, Ph.D Less <<
NCT00268242 Leukemia Phase 2 Terminated(If ... More >>tial 18 patients had a CR, the study would be stopped. Only 5 patients (21%) of 24 enrolled patients had a CR so the study was terminated.) Less << - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00940524 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02686593 Acute Myeloid Leukemia Phase 2 Completed - Hong Kong ... More >> The University of Hong Kong Hong Kong, Hong Kong Less <<
NCT01839240 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting September 2018 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT01701375 - Terminated(Material sponsor wi... More >>thdrew support) Less << - -
NCT00477087 Prostatic Neoplasms Phase 2 Terminated(Low accrual) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00660036 Acute Myeloid Leukemia Phase 1 Terminated(due to new safety i... More >>nformation) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT03258320 Prostate Cancer Patients Phase 1 Recruiting December 2020 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Qingdao, Shandong, China, 266035 Contact: Jiannan Chen, Ph.D ?? 86-0532-96599654 ?? submarinesuny@yahoo.com ?? China Zhongshan Hospital Recruiting Shanghai, China, 200032 Contact: Qilai Long, Ph.D ?? 86-15821758764 ?? long.qilai@zs-hospital.sh.cn Less <<
NCT01594918 Metastatic Castration-resistan... More >>t Prostate Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00477087 - Terminated(Low accrual) - -
NCT02596373 Advanced Recurrent or Metastat... More >>ic Breast Cancer Less << Phase 2 Recruiting September 2018 China ... More >> Fudan University Cancer Hospital Recruiting Shanghai, China Contact: Xichun Hu, Ph.D ?? +8613816110335 ?? xchu2009@hotmail.com ?? Principal Investigator: Xichun Hu, Ph.D Less <<
NCT02021825 Neuromyelitis Optica|Neuromyel... More >>itis Optica Spectrum Disorders Less << PHASE4 UNKNOWN 2025-12-15 Department of Neurology, Xuanw... More >>u Hospital, Capital Medical University, Beijing, Beijing, 100053, China Less <<
NCT01701375 Relapsed Acute Leukemia ... More >> Refractory Acute Leukemia High-Risk Myelodysplasia Less << Phase 1 Terminated(Material sponsor wi... More >>thdrew support) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, New York Weill Cornell Medical Center New York, New York, United States, 10065 Less <<
NCT02131688 Malignant Lymphoma Phase 1 Unknown October 2015 China ... More >> Cancer Hospital ,Chinese Academy of Mddical Sciences Recruiting Beijing, China Contact: Yuankai Shi, Ph.D ?? 010-87788701 ?? ?? Principal Investigator: Yuankai Shi, Ph.D ?? ?? ?? Sub-Investigator: Jianliang Yang, Ph.D Less <<
NCT03776279 Relapsed or Refractory Periphe... More >>ral T-cell and NK/T-cell Lymphoma Less << Phase 2 Recruiting December 30, 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Huiqiang Huang, Doctor ?? 020-87343350 Less <<
NCT01627938 Multiple Sclerosis Phase 2 Unknown April 2016 Germany ... More >> Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum Bochum, Germany, 44791 Less <<
NCT02043756 Neoplasms Phase 1 Completed - -
NCT00882076 Leukemia Phase 1 Completed - United States, Pennsylvania ... More >> Penn State Hershey Cancer Institute Hershey, Pennsylvania, United States, 17033 Less <<
NCT01842672 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Lymphoblastic Lymphoma Diffuse Large B-cell Lymphoma Burkitt Lymphoma/Leukemia Less << Phase 1 Phase 2 Recruiting December 2018 United States, New York ... More >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell Cairo, MD ?? 914-594-3650 ?? mitchell_cairo@nymc.edu ?? Contact: Lauren Harrison, MSN ?? 617-285-7844 ?? lauren_harrison@nymc.edu ?? United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Javier Oesterheld, MD ?? 704-381-9900 ?? Javier.Oesterheld@carolinashealthcare.org Less <<
NCT00060684 Lymphoma, Low-Grade ... More >> Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Maryland Greater Baltimore Medical Center Baltimore, Maryland, United States, 21204 United States, New Mexico New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States, 87109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00002700 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT00317096 Lymphoma, Follicular ... More >> Lymphoma, Low-Grade Lymphoma, Intermediate-Grade Less << Phase 3 Active, not recruiting June 2021 Germany ... More >> German Low Grade Study Group (Glsg) Munich, Germany, D-81377 Less <<
NCT00003728 Leukemia Lymp... More >>homa Less << Phase 3 Unknown - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Ghent University Ghent, Belgium, B-9000 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34059 CHR Hotel Dieu Nantes, France, 44035 Hopital de l'Archet CHU de Nice Nice, France, F-06202 CHU - Hopital Robert Debre Paris, France, 75019 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Instituto Portugues de Oncologia Centro do Porto, SA Porto, Portugal, 4200 Less <<
NCT00003893 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2TH Less <<
NCT00002701 Leukemia Phase 3 Unknown - -
NCT00003215 Lymphoma Phase 3 Completed - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Germany Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Greece Saint Savvas Cancer Hospital of Athens Athens, Greece, 11522 Italy European Institute of Oncology Milano, Italy, 20141 Switzerland Universitatsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital, Bern Bern, Switzerland, CH-3010 Ratisches Kantons und Regionalspital Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Collonge-Bellerive, Switzerland, CH-1245 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT00003650 Lymphoma Phase 3 Unknown - France ... More >> Centre Leon Berard Lyon, France, 69373 Less <<
NCT00070174 Leukemia Phase 2 Completed - -
NCT00002531 Leukemia Phase 2 Unknown - Germany ... More >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less <<
NCT00005985 Lymphoma Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00005987 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Terminated(Withdrawn because t... More >>reatment guidelines changed) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00005802 Leukemia Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00002517 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT00004197 Lymphoma Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 Less <<
NCT00032149 Lymphoma Phase 1 Phase 2 Unknown - United Kingdom ... More >> Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN St. Georges, University of London London, England, United Kingdom, SW17 ORE King's College Hospital London, England, United Kingdom, W1T 4TJ Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT00003436 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00317408 Lymphoma Not Applicable Unknown - -
NCT00002905 Lymphoma Phase 2 Unknown - Italy ... More >> Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Less <<
NCT00458848 Leukemia Phase 2 Completed - -
NCT00002658 Leukemia Neut... More >>ropenia Less << Phase 3 Unknown - United Kingdom ... More >> University of Wales College of Medicine Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT00550992 Leukemia Not Applicable Unknown - United States, Massachusetts ... More >> Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis B. Silverman, MD ?? 617-632-5285 ?? ?? United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Clinical Trials Office - St. Jude Children's Research Hospital ?? 901-595-4644 ?? ?? United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U ?? 713-792-3245 ?? ?? United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Blythe Thomson, MD ?? 206-987-2106 ?? ?? Austria St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Georg Mann, MD ?? 43-1-4017-1250 ?? ?? Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Alice Ferster, MD ?? 32-2-477-2678 ?? aferster@ulb.ac.be ?? Czech Republic University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD ?? 420-2-2443-6401 ?? jan.stary@lfmotol.cuni.cz ?? France CHR Hotel Dieu Recruiting Nantes, France, 44093 Contact: Francoise Mechinaud, MD ?? 33-1-4249-9046 ?? ?? Germany University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub ?? 49-404-2803-2580 ?? ?? Medizinische Hochschule Hannover Recruiting Hannover, Germany, D-30625 Contact: Martin Schrappe, MD, PhD ?? 49-511-532-6713 ?? ?? Italy Nuovo Ospedale San Gerardo at University of Milano-Bicocca Recruiting Monza, Italy, 20052 Contact: Andrea Biondi, MD ?? 39-039-233-3661 ?? biondi@galactica.it ?? Netherlands Erasmus MC - Sophia Children's Hospital Recruiting Rotterdam, Netherlands, 3015 GJ Contact: Rob Pieters, MD, MSC, PhD ?? 31-10-463-6691 ?? rob.pieters@erasmusmc.nl ?? United Kingdom Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Phil Ancliff, MD ?? 44-20-7829-8831 Less <<
NCT00199069 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany Less <<
NCT00556127 Diffuse Large B-Cell Lymphoma ... More >> POOR PROGNOSIS Less << Phase 2 Completed - Italy ... More >> Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Ospedale Regionale, Divisione di Oncologia, Aosta, Italy Azienda Ospedaliera Ospedale Policlinico Consorziale Bari, Italy Osp. degli Infermi Biella, Italy Spedali Civili Brescia, Italy Centro Trapianti Midollo Osseo, P.O. Businco Cagliari, Italy Ospedale S. Gerardo Monza, Italy Osp. maggiore della Carità Novara, Italy Università degli Studi Policlinico Monteluce Perugia, Italy Divisione di Medicina, Ospedale Generale E. Agnelli, Pinerolo Torino, Italy Istituto per la Ricerca e la Cura del Cancro, Candiolo Torino, Italy Osp. S. Giovanni Battista "Molinette" Torino, Italy Ospedale di Chivasso e Ivrea Torino, Italy Stabilimento Ospedaliero Ciriè - Torino, Italy Less <<
NCT00499018 Diffuse Large B-Cell Lymphoma ... More >> IPI≥2 Less << Phase 3 Unknown September 2013 -
NCT00526305 Acute Lymphoblastic Leukemia Phase 4 Completed - -
NCT00002549 Leukemia Phase 3 Unknown - -
NCT00002719 Leukemia Neut... More >>ropenia Less << Phase 3 Completed - Italy ... More >> Azienda Policlinico Umberto Primo Rome, Italy, 00161 Less <<
NCT00840684 Leukemia Phase 1 Phase 2 Completed - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Less <<
NCT00774826 Follicular Lymphoma Phase 3 Unknown March 2014 -
NCT00005998 Lymphoma Phase 2 Withdrawn(Withdrawn because st... More >>udy never enrolled patients) Less << - -
NCT00003957 Lymphoma Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT03736382 Obstructive Sleep Apnea Not Applicable Recruiting October 2020 United States, Michigan ... More >> John D Dingell VA Medical Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jason H Mateika, Ph.D. ?? 313-576-4481 ?? am1819@wayne.edu ?? Contact: Raichel M Alex, Ph.D. ?? 313-576-4454 ?? gm9041@wayne.edu ?? Principal Investigator: Jason H Mateika, Ph.D. ?? ?? ?? Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Jason H Mateika, Ph.D. ?? 313-576-4481 ?? am1819@wayne.edu ?? Contact: Raichel M Alex, Ph.D. ?? 313-576-4454 ?? gm9041@wayne.edu ?? Principal Investigator: Jason H Mateika, Ph.D. Less <<
NCT02101853 B Acute Lymphoblastic Leukemia Phase 3 Recruiting - -
NCT00866918 Childhood Acute Promyelocytic ... More >>Leukemia (M3) Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - -
NCT02523976 Acute,Leukemia, Lymphoid Phase 2 Enrolling by invitation August 2019 China, Tianjin ... More >> Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin, China, 300020 Less <<
NCT03250338 Relapsed/Refractory Acute Myel... More >>oid Leukemia With FLT3 Activating Mutations Less << Phase 3 Recruiting October 2021 United States, California ... More >> UC Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian Jonas, MD ?? 916-734-5959 ?? ?? United States, Kansas Kansas University Recruiting Kansas City, Kansas, United States, 666160 Contact: Sunil Abhyankar, MD ?? ?? ?? Principal Investigator: Sunil Abhyankar, MD ?? ?? ?? United States, Michigan Karmanos Cancer Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jay Yang, MD ?? ?? yangj@karmanos.org ?? Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Yue Guo, MD ?? ?? ?? Principal Investigator: Yue Guo, MD ?? ?? ?? United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Eunice Wang, MD ?? ?? ?? Principal Investigator: Eunice Wang, MD Less <<
NCT00071799 Myelodysplastic Syndromes Phase 3 Completed - -
NCT00071799 - Completed - -
NCT02339740 Acute Promyelocytic Leukemia W... More >>ith PML-RARA Less << Phase 3 Recruiting - -
NCT03165851 - Completed - China, Tianjin ... More >> InstituteHBDH Tianjin, Tianjin, China, 300020 Less <<
NCT00866918 - Completed - -
NCT00107354 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00005823 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2RR University College Hospital London, England, United Kingdom, WC1E 6AU University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT02421939 Leukemia, Acute Myeloid (AML) Phase 3 Active, not recruiting December 2020 -
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT00869284 Lymphoma Phase 2 Completed - France ... More >> Emmanuel Gyan Tours, France, 37000 Less <<
NCT02907359 Myelodysplastic Syndromes ... More >> Leukemia, Myelomonocytic, Chronic Less << Phase 3 Recruiting December 2019 -
NCT00003080 Ovarian Cancer Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00853008 Acute Lymphoblastic Leukemia Phase 4 Active, not recruiting January 2019 Spain ... More >> Hospital General Alicante, Spain Hospital Germans Trias i Pujol Badalona, Spain Clínica Teknon Barcelona, Spain Hospital Clínic i Provincial Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Hospital Duran y Reynals Barcelona, Spain Hospital Vall d'Hebrón Barcelona, Spain Hospital General Castellón, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Josep Trueta Girona, Spain Hospital Universitario Guadalajara, Spain Hospital Juan Canalejo La Coru?a, Spain Hospital Xeral Lugo, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico Universitario Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Carlos Haya Málaga, Spain Hospital Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital Clínico Universitario Salamanca, Spain Hospital Marqués de Valdecilla Santander, Spain Hospital Xeral Santiago, Spain Hospital Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Mútua de Terrassa Terrassa, Spain Hospital Clínico Universitario Valencia, Spain Hospital Dr Pesset Valencia, Spain Hospital General Valencia, Spain Hospital La Fe Valencia, Spain Hospital Clínico Valladolid, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT01497002 Acute Myeloid Leukaemia Phase 3 Unknown December 2013 Germany ... More >> University of Leipzig, Hematology Recruiting Leipzig, Germany, 04103 Principal Investigator: Dietger Niederwieser Less <<
NCT02039726 AML Phase 3 Active, not recruiting July 2019 -
NCT01371981 Acute Myeloid Leukemia ... More >> Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma Untreated Adult Acute Myeloid Leukemia Untreated Childhood Myeloid Neoplasm Less << Phase 3 Active, not recruiting - -
NCT00031187 Prostatic Neoplasms Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Arkansas Highlands Oncology Group Springdale, Arkansas, United States, 72764 United States, California West Los Angeles - VA Healthcare Center Los Angeles, California, United States, 90073 VA Medical Center of Palo Alto Palo Alto, California, United States, 94304 Sharp HealthCare, Sidney Kimmel Cancer Center San Diego, California, United States, 92121 United States, Connecticut Bendheim Cancer Center Greenwich, Connecticut, United States, 06830 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Broward Oncology Associates Ft. Lauderdale, Florida, United States, 33308 Innovative Medical Research of South Florida Miami Shores, Florida, United States, 33138 United States, Michigan St. Joseph Mercy Oakland Hospital Pontiac, Michigan, United States, 33308 United States, Virginia Arlington Fairfax Hematology-Oncology, P.C. Arlington, Virginia, United States, 22205 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office ?? 888-624-1937 Less <<
NCT03150004 Acute Myeloid Leukemia Phase 2 Recruiting June 1, 2020 United States, Wisconsin ... More >> Froedtert & the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Medical College of Wisconsin Clinical Cancer Center ?? 414-805-8900 ?? cccto@mcw.edu Less <<
NCT00006122 Leukemia Phase 2 Completed - Austria ... More >> Innsbruck Universitaetsklinik Innsbruck, Austria, A-6020 Belgium A.Z. St. Jan Brugge, Belgium, 8000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 CHU Sart-Tilman Liege, Belgium, B-4000 Croatia University Hospital Rebro Zagreb, Croatia, 41000 France Hopital Edouard Herriot Lyon, France, 69437 Hotel Dieu de Paris Paris, France, 75181 Hopital Necker Paris, France, 75743 Germany Medizinische Klinik und Poliklinik Heidelberg, Germany, D-69115 Eberhard Karls Universitaet Tuebingen, Germany, D-72076 Italy Ospedale Generale Regionale Bolzano, Italy, 39100 Ospedali Riuniti Reggio Calabria, Italy, 89100 Ospedale San Eugenio Rome, Italy, 00144 Azienda Policlinico Umberto Primo Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Netherlands Groot Ziekengasthuis 's-Hertogenbosch 's-Hertogenbosch, Netherlands, 5211 NL Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Less <<
NCT03616470 Acute Myeloid Leukemia Phase 3 Recruiting December 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel J DeAngelo, MD, PhD ?? 617-632-2645 ?? Daniel_Deangelo@dfci.harvard.edu ?? Principal Investigator: Daniel DeAngelo, MD, PhD ?? ?? ?? United States, New York University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Brandon DeLorme ?? 585-275-5295 ?? Brandon_Delorme@URMC.Rochester.edu ?? Principal Investigator: Jane Liesveld, MD ?? ?? ?? United States, Ohio The Ohio State University Wexner Medical Center and James Cancer Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Jennifer Dienno ?? 614-293-0752 ?? Jennifer.Dienno@osumc.edu ?? Principal Investigator: Alice Mims, MD ?? ?? ?? United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naval Daver, MD ?? 713-794-4392 ?? NDaver@mdanderson.org ?? Principal Investigator: Naval Daver, MD ?? ?? ?? United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Niall Curley ?? 206-606-1231 ?? Ncurley8@seattlecca.org ?? Principal Investigator: Pamela Becker, MD, PhD Less <<
NCT00003032 Breast Cancer Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6ZB Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario William Osler Health Centre Brampton, Ontario, Canada, L6W 2Z8 Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Hotel Dieu Hospital - St. Catharines St. Catharines, Ontario, Canada, L2R 5K3 Northeastern Ontario Regional Cancer Centre, Sudbury Sudbury, Ontario, Canada, P3E 5J1 Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay, Ontario, Canada, P7A 7T1 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Weston, Ontario, Canada, M9N 1N8 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island Queen Elizabeth Hospital, PEI Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec L'Hotel Dieu de Levis Levis, Quebec, Canada, G6V 3Z1 Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 McGill University Department of Oncology Montreal, Quebec, Canada, H2W 1S6 Hotel Dieu de Montreal Montreal, Quebec, Canada, H2W 1T8 Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec Quebec City, Quebec, Canada, G1R 2J6 Less <<
NCT00052299 Leukemia Phase 3 Completed - -
NCT00146120 Acute Myeloid Leukemia Phase 3 Completed - Austria ... More >> Department of Hematology / Oncology, University Hospital of Innsbruck Innsbruck, Austria, 6020 III Medical Department, Hematology and Oncology Center, Hanuschhospital Wien Wien, Austria, 1140 Germany Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Department of Internal Medicine Hematology, Heinrich-Heine University Düsseldorf, Germany, 40225 Department of Interial Medicine III, City Hospital Frankfurt Am Main - H?chst Frankfurt, Germany, 65927 Medical Department IV, University of Gie?en Gie?en, Germany, 35392 Department of Interial Medicine, Wilhelm-Anton-Hospital Goch Goch, Germany, 47574 Centre of Interial Medicine, University of G?ttingen G?ttingen, Germany, 37075 Medical Department III of Hematology and Oncology, General Hospital Altona Hamburg, Germany, 22763 Department of Interial Medicine V, University of Heidelberg Heidelberg, Germany, 69120 Department of Interial Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Interial Medicine /Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 I. Medical Department, City Hospital München-Schwabing München, Germany, 80804 Medical Department III, Clinical Center rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, City Hospital Neunkirchen gGmbH Neunkirchen, Germany, 66538 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematologie and Oncology, Caritas Hospital St. Theresa Saarbrücken Saarbrücken, Germany, 66113 Clinikal Cetner of Stuttgart, Center of Oncology Stuttgart, Germany, 70174 Medical Department I, Clinical Center of Stuttgart Stuttgart, Germany, 70191 Hospital of Barmherzige Brüder, I Medical Department Trier, Germany, 54292 Less <<
NCT00273364 Multiple Sclerosis Phase 2 Active, not recruiting December 2018 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT03164057 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting June 2027 United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD ?? 800-826-4673 ?? weilisun@coh.org ?? Principal Investigator: Weili Sun, MD,PhD ?? ?? ?? Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD ?? 866-353-5437 ?? frazzaqi@valleychildrens.org ?? Principal Investigator: Faisal Razzaqi, MD ?? ?? ?? Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD ?? 714-509-4348 ?? jfrediani@choc.org ?? Principal Investigator: Jamie Frediani, MD ?? ?? ?? Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD ?? 650-497-8953 ?? lacayon@stanford.edu ?? Principal Investigator: Norman J. Lacayo, MD ?? ?? ?? Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD ?? 858-966-5983 ?? dschiff@chsd.org ?? Principal Investigator: Deborah Schiff, MD ?? ?? ?? United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD ?? 866-278-5833 ?? tanja.gruber@stjude.org ?? Contact: Referral Office ?? 866-278-5833 ?? referralinfo@stjude.org ?? Principal Investigator: Tanja A. Gruber, MD, PhD ?? ?? ?? United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD ?? 682-885-4007 ?? kenneth.heym@cookchildrens.org ?? Principal Investigator: Kenneth M. Heym, MD Less <<
NCT00586755 Mantle Cell Lymphoma Phase 2 Completed - -
NCT00006250 Lymphoma Phase 3 Unknown - -
NCT00003602 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Unknown - United Kingdom ... More >> Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Less <<
NCT01039363 Acute Myeloid Leukemia Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Principal Investigator: Dong Hwan Won, M.D.,Ph.D. Less <<
NCT00006045 Leukemia Phase 3 Unknown - -
NCT02044354 Metastatic Castration-resistan... More >>t Prostate Cancer Less << Phase 3 Active, not recruiting April 2018 France ... More >> Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT03356912 Prostate Cancer ... More >> Castration-resistant Prostate Cancer Less << Phase 2 Enrolling by invitation May 4, 2021 Italy ... More >> University Federico II of Naples Naples, Italy Less <<
NCT00151255 Acute Myeloid Leukemia Phase 3 Completed - Austria ... More >> Department of Hematology/Oncology, University Hospital of Innsbruck Innsbruck, Austria, 6020 Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern Linz, Austria, 4010 Medical Department III, St. Johann Hospital Salzburg, Austria, 5020 Center of hematology and oncology, Hanusch Hospital Wien, Austria, 1140 Germany Department of Internal Medicine I, Central Hospital of Augsburg Augsburg, Germany, 86856 Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Medical Department I, Hospital of Bremen-Mitte Bremen, Germany, 28177 Department of Hematology and Oncology, Hospital Essen-Süd, Ev. Hospital of Essen-Werden Essen, Germany, 45239 Department of Internal Medicine III, City Hospital Frankfurt am Main - H?chst Frankfurt, Germany, 65929 Medical Department IV, University Hospital of Giessen Giessen, Germany, 35392 Department of Internal Medicine, Wilhelm-Anton Hospital gGmbH Goch, Germany, 47574 Centre of Internal Medicine, University Hospital of G?ttingen G?ttingen, Germany, 37075 Department of Oncology and Hematology, University Hospital Eppendorf Hamburg, Germany, 20246 Medical Department II, General Hospital Altona Hamburg, Germany, 22763 Medical Department III, Hospital of Hanau Hanau, Germany, 63450 Medical Department III, Hospital of Hannover-Siloah Hannover, Germany, 30449 Department of Internal Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Internal Medicine/Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 Department of Hematology/Oncology, Clinical Center of Lüdenscheid Lüdenscheid, Germany, 58515 Medical Department III, Clinical Center Rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematology and Oncology/Caritas Hospital St. Theresa Saarbrücken, Germany, 66113 Department of Oncology, Clinical Center of Stuttgart Stuttgart, Germany, 70174 Medical Department II, Diakonie Hospital Stuttgart, Germany, 70176 I. Medical Department, Hospital of Barmerzigen Brüder Trier, Germany, 54292 Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen Villingen - Schwenningen, Germany, 78050 Medical Department I, Helios Hospital Wuppertal Wuppertal, Germany, 42283 Less <<
NCT02028650 - Completed - China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences Beijing, Beijing, China, 100071 Less <<
NCT02288936 Hormone-refractory Prostate Ca... More >>ncer Less << Phase 2 Active, not recruiting January 2019 Spain ... More >> Hospital Universitari Germans Trias I Pujol de Badalona Badalona, Barcelona, Spain, 08916 Hospital Universitari Son Espases Palma de Mallorca, Islas Baleares, Spain, 07120 Hospital Clinic I Provincial de Barcelona Barcelona, Spain, 08036 Hospital Parc Taulí Barcelona, Spain Complejo Hospitalario Regional Reina Sofía Córdoba, Spain, 14004 Complejo Asistencial Universitario de Leon León, Spain, 24080 Hospital Universitario Lucus Augusti Lugo, Spain, 27003 Hospital Ramón Y Cajal Madrid, Spain, 28034 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital General Universitario J.M. Morales Meseguer Murcia, Spain, 30008 Complejo Hospitalario de Especialidades Virgen de La Victoria Málaga, Spain, 29010 Complexo Hospitalario Universitario de Ourense Ourense, Spain, 32005 Complejo Hospitalario Regional Virgen Del Rocio Sevilla, Spain, 41013 Fundación Instituto Valenciano de Oncologia Valencia, Spain, 46009 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00088530 Lymphoma, Non-Hodgkin Phase 3 Completed - -
NCT00088530 - Completed - -
NCT00002565 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Brazil Faculdade de Medicina do ABC Sao Paulo, Brazil, 01224--010 Chile Clinica Alemana Santiago, Chile, 5951 Less <<
NCT01541007 Metastatic Castration Resistan... More >>t Prostate Cancer Less << Phase 2 Completed - Sweden ... More >> Deapartment of Oncology Karolinska University Hospital Stockholm, Sweden, 171 76 Less <<
NCT02920008 Acute Myeloid Leukemia Phase 3 Active, not recruiting December 2019 -
NCT02688140 Acute Promyelocytic Leukemia Phase 3 Recruiting January 2022 France ... More >> French-Belgian-Swiss APL study group Not yet recruiting Multiple Locations, France Contact: Pierre Fenaux, Prof. Dr. ?? ?? pierre.fenaux@avc.ap-hop-paris.fr ?? Contact: Lionel Ades, Dr. ?? ?? lionel.ades@sls.aphp.fr ?? Germany AML-CG study group Recruiting Multiple Locations, Germany Contact: Eva Lengfelder, Prof. Dr. ?? ?? Eva.Lengfelder@umm.de ?? AML-SG study group Recruiting Multiple Locations, Germany Contact: Richard F. Schlenk, Prof. Dr. ?? ?? Richard.Schlenk@uniklinik-ulm.de ?? OSHO study group Recruiting Multiple Locations, Germany Contact: Dietger Niederwieser, Prof. Dr. ?? ?? Dietger.Niederwieser@medizin.uni-leipzig.de ?? SAL study group Recruiting Multiple Locations, Germany Contact: Uwe Platzbecker, Prof. Dr. ?? +49 351 458 ext 3192 ?? uwe.platzbecker@uniklinikum-dresden.de ?? Contact: Michaela Sauer ?? +49 351 458 ext 3192 ?? michaela.sauer@uniklinikum-dresden.de ?? Italy GIMEMA study group Not yet recruiting Multiple Locations, Italy Contact: Francesco Lo-Coco, Prof. Dr. ?? ?? Francesco.lo.coco@uniroma2.it ?? Contact: Fabio Efficace, Dr. ?? ?? f.efficace@gimema.it ?? Netherlands HOVON study group Not yet recruiting Multiple Locations, Netherlands Contact: Edo Vellenga, Prof. Dr. ?? ?? e.vellenga@umcg.nl ?? Spain PETHEMA study group Not yet recruiting Multiple Locations, Spain Contact: Miguel A. Sanz, Prof. Dr. ?? ?? sanz_mig@gva.es ?? Contact: Pau Montesinos, Prof. Dr. ?? ?? montesinos_pau@gva.es Less <<
NCT02644044 To Evaluate the Effect of Ther... More >>apy With IT MTX on the Disease Course of Patients With Progressive MS Less << Early Phase 1 Unknown January 2018 -
NCT00577161 Non-Hodgkin's Lymphoma Phase 3 Terminated(closed to enrollmen... More >>t) Less << July 2012 United States, Alabama ... More >> Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States, 35661 United States, California Ventura County Hematology Oncology Specialist Oxnard, California, United States, 93030 United States, Missouri Capitol Comprehensive Cancer Care Jefferson City, Missouri, United States, 65109 Heartland Hematology Oncology Associates Kansas City, Missouri, United States, 64118 United States, New York Cancer Care Center New Albany, New York, United States, 47150 Interlakes Foundation, Inc. Rochester, New York, United States, 14623 United States, Ohio Hematology Oncology Consultants Columbus, Ohio, United States, 43235 United States, Utah Utah Hematology Oncology, P.C. Ogden, Utah, United States, 84403 Less <<
NCT02072811 Acute Myeloid Leukemia Phase 3 Unknown February 2018 Poland ... More >> Copernicus Memorial Hospital Recruiting Lodz, Poland, 93-510 Principal Investigator: Agnieszka Wierzbowska, Dr hab. n. med. Less <<
NCT00028899 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Completed - -
NCT00712582 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03257241 Acute Myeloid Leukemia Phase 3 Recruiting December 31, 2020 Poland ... More >> Medical University of Bialystok Clinical Hospital Recruiting Bia?ystok, Poland, 15-276 Contact: Jaros?aw Piszcz, Dr ?? ?? ?? Markiewicz Memorial Oncology Center Brzozow Recruiting Brzozów, Poland, 36-200 Contact: Andrzej Pluta, Dr ?? ?? ?? University Clinical Centre in Gdansk Recruiting Gdańsk, Poland, 80-210 Contact: Maria Bieniaszewska, Dr ?? ?? ?? Holycross Cancer Center Recruiting Kielce, Poland, 25-001 Contact: Marzena W?tek, Dr ?? ?? ?? Ludwik Rydygier Memorial Specialized Hospital Recruiting Kraków, Poland, 30-001 Contact: Ma?gorzata Ra?ny, Dr ?? ?? ?? Regional Specialised Hospital in Legnica Recruiting Legnica, Poland, 59-220 Contact: Jadwiga Ho?ojda ?? ?? ?? Independent Public University Hospital No. 1 in Lublin Recruiting Lublin, Poland, 20-001 Contact: Marek Hus, Prof. ?? ?? ?? Clinical Hospital at the Karol Marcinkowski Medical University in Poznan Recruiting Poznań, Poland, 60-355 Contact: MAciej Ka?mierczak, Dr ?? ?? ?? Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Recruiting ?ód?, Poland, 93-513 Contact: Agnieszka Wierzbowska, Prof. ?? +48426895191 ?? agawierzbowska@wp.pl Less <<
NCT00278993 Prostate Cancer Phase 2 Completed - United States, Colorado ... More >> Dr. Robert Jotte Denver, Colorado, United States, 80218 United States, Florida Melbourne Internal Medicine Associates Melbourne, Florida, United States, 32901 Ocala Oncology Center PL Ocala, Florida, United States, 34474 United States, Indiana Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46227 United States, Minnesota Minnesota Hematology Oncology Burnsville, Minnesota, United States, 33557 United States, Missouri Missouri Cancer Associates Columbia, Missouri, United States, 65201 United States, New York New York Oncology Hematology, P.C. Albany, New York, United States, 12208 St. Luke's Roosevelt Hospital Center New York, New York, United States, 10019 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Raleigh Hematology Oncology Associates PL Raleigh, North Carolina, United States, 27607 United States, Texas US Oncology Dallas, Texas, United States, 75204 Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 El Paso Cancer Treatment Center El Paso, Texas, United States, 79915 Texas Oncology PA Fort Worth, Texas, United States, 76104 Texas Oncology PA Tyler, Texas, United States, 75702 Tyler Cancer Center Tyler, Texas, United States, 75702 Deke Slayton Cancer Center Webster, Texas, United States, 77598 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23505 Less <<
NCT00562965 Lymphoma, Follicular Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01779479 Primary Breast Cancer Phase 2 Completed - Germany ... More >> Luisenkrankenhaus Düsseldorf, Germany, 40235 Less <<
NCT00562965 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00372593 Leukemia Phase 3 Completed - -
NCT02521493 Blasts 5 Percent or More of Bo... More >>ne Marrow Nucleated Cells Childhood Acute Myeloid Leukemia Childhood Myelodysplastic Syndrome Cytopenia Down Syndrome Myeloid Leukemia Associated With Down Syndrome Myeloproliferative Neoplasm Trisomy 21 Trisomy 21 Mosaicism Less << Phase 3 Recruiting - -
NCT02626338 Relapsed/Refractory Acute Myel... More >>oid Leukemia (AML) Less << Phase 1 Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope Medical Center Duarte, California, United States, 91010 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Houston Methodist Houston, Texas, United States, 77030 Less <<
NCT00372593 - Completed - -
NCT00414388 Prostate Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Onocology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT00278993 - Completed - -
NCT00414388 - Completed - -
NCT00002835 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT02303821 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 1 Recruiting October 18, 2019 -
NCT02879643 ALL, Childhood ... More >> Lymphoblastic Leukemia, Acute, Childhood Lymphoblastic Leukemia, Acute Less << Phase 1 Recruiting May 1, 2021 -
NCT00744081 AML Phase 2 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany Less <<
NCT00109837 Leukemia Phase 2 Completed - -
NCT03182244 Acute Myeloid Leukemia With FM... More >>S-like Tyrosine Kinase (FLT3) Mutation Less << Phase 3 Recruiting June 2020 -
NCT00109837 - Completed - -
NCT03173612 Acute Myeloid Leukemia Not Applicable Recruiting December 2022 China, Tianjin ... More >> InstituteHBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Zhu Xiaofan ?? 86-21-23909001 ?? xfzhu@ihcams.ac.cn ?? Principal Investigator: Guo Ye ?? ?? ?? Principal Investigator: Yang Wenyu ?? ?? ?? Principal Investigator: Chen Xiaojuan ?? ?? ?? Principal Investigator: Chen Yumei ?? ?? ?? Principal Investigator: Ruan Min Less <<
NCT00180102 Leukemia, Nonlymphocytic, Acut... More >>e Less << Phase 4 Completed - Germany ... More >> Medical Department I, University Hospital Carl Gustav Carus Dresden, Germany, 01307 Less <<
NCT00906945 Leukemia, Myeloid, Acute Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00906945 - Completed - -
NCT00079482 Acute Myeloid Leukemia Phase 2 Completed - -
NCT01004497 Acute Lymphoblastic Leukemia Phase 2 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonju, Chonbuk, Korea, Republic of, 561-712 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 National Cancer Center Goyang, Gyeonggi-do, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-809 St. Vincent's Hospital, The Catholic University of Korea Suwon, Kyonggi-do, Korea, Republic of, 442-723 Yonsei University Severance Hospital Seoul, Korea, Republic of, 120-752 Catholic BMT Center, Seoul St. Mary's Hospital, The Catholic University of Korea Seoul, Korea, Republic of, 137-701 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Less <<
NCT03072238 Metastatic Prostate Cancer Phase 3 Recruiting November 18, 2023 -
NCT01795872 Multiple Sclerosis Phase 4 Completed - -
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker ?? 206-616-1589 ?? pbecker@u.washington.edu ?? Principal Investigator: Pamela S. Becker Less <<
NCT02559765 - Completed - United Kingdom ... More >> The University of Glasgow Glasgow, United Kingdom, G12 8LL Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.25mL

0.45mL

0.22mL

11.25mL

2.25mL

1.12mL

22.50mL

4.50mL

2.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories